RossDavidMerkinMD(He/Him)

Oncology • Boston, MA

Head & Neck Cancer

Medical Oncologist

Join to view full profile

Dr. Merkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Merkin's full profile

Already have an account?

Office
55 Fruit St
Boston, MA 02114
Phone+1 617-724-4000
Is this information wrong?

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Montefiore Medical Center/Albert Einstein College of Medicine (New Rochelle)Chief Residency, Internal Medicine, 2019 - 2020
Montefiore Medical Center/Albert Einstein College of Medicine (New Rochelle)Residency, Internal Medicine, 2016 - 2019
Stony Brook University Health Sciences Center School of MedicineClass of 2016

Certifications & Licensure

MA State Medical License 2023 - 2026
CT State Medical License 2020 - 2023
NY State Medical License 2019 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

2 citations
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
David A Schoenfeld, Myrto Moutafi, Sandra Martinez, Dijana Djureinovic, Ross D Merkin, Adebowale Adeniran, David A Braun, Sabina Signoretti, Toni K Choueiri, Fabio Par...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
1 citations
ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis.
Jacqueline E Mann, Liliana Lucca, Matthew R Austin, Ross D Merkin, Marie E Robert, Badr Al Bawardy, Khadir Raddassi, Lilach Aizenbud, Nikhil S Joshi, David A Hafler, C...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
1 citations
Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?
Ross D Merkin, Veronica L Chiang, Sarah B Goldberg> ;Therapeutic Advances in Medical Oncology. 2023 Jan 1
8 citations
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognosti...
David A Schoenfeld, Ross D Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar, Lucia Jilaveanu, Michael Hurwitz, David L Rimm, Harriet M Kluger> ;Frontiers in Oncology. 2022 Jan 1
5 citations
Internal Medicine Resident Work Absence During the COVID-19 Pandemic at a Large Academic Medical Center in New York City.
Ross Merkin, Ariel Kruger, Gaurav Bhardwaj, Grace R. Kajita, Lauren C. Shapiro, Benjamin T. Galen> ;Journal of Graduate Medical Education. 2020 Dec 1
36 citations
Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer
Ross D. Merkin, Elizabeth A. Vanner, Jamie L. Romeiser, A. Laurie Shroyer, Luisa F. Escobar-Hoyos, Jinyu Li, Robert S. Powers, Stephanie Burke, Kenneth R. Shroyer> ;Human Pathology. 2017 Apr 1
157 citations
99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
Shawn Hillier, Kevin P. Maresca, Genliang Lu, Ross D. Merkin, John C. Marquis, Craig Zimmerman, William C. Eckelman, John Joyal, John W. Babich> ;Journal of Nuclear Medicine. 2013 Aug 1
Join now to see all

Hospital Affiliations

Massachusetts General HospitalBoston, Massachusetts